Skinvisible (SKVI) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2019)
Powered by 
Analysis
Skinvisible (SKVI) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2019) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.12 Bn | 626.36 Bn | 17.26 Bn | 4.65% |
| 2 | AbbVie | 440.93 Bn | 434.36 Bn | 12.70 Bn | 5.45% |
| 3 | Merck | 364.34 Bn | 357.20 Bn | 12.21 Bn | 5.00% |
| 4 | Novartis Ag | 268.31 Bn | 260.62 Bn | 11.24 Bn | -0.43% |
| 5 | Pfizer | 158.49 Bn | 146.79 Bn | 10.94 Bn | 2.85% |
| 6 | Sanofi | 52.52 Bn | 45.14 Bn | 10.79 Bn | 3.06% |
| 7 | Revolution Medicines | 44.27 Bn | 44.27 Bn | - | - |
| 8 | Incyte | 25.01 Bn | 20.47 Bn | 1.57 Bn | -1.81% |
| 9 | United Therapeutics | 21.18 Bn | 18.51 Bn | 683.80 Mn | 27.15% |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | -64.33% |
| Dec 31, 2018 | -58.86% |
| Sep 30, 2018 | -56.09% |
| Jun 30, 2018 | -54.38% |
| Mar 31, 2018 | -53.21% |
| Dec 31, 2017 | -52.14% |
| Sep 30, 2017 | -50.69% |
| Jun 30, 2017 | -43.46% |
| Dec 31, 2016 | -42.30% |
| Jun 30, 2016 | -40.18% |
| Mar 31, 2016 | -34.20% |
| Dec 31, 2015 | -27.56% |
| Sep 30, 2015 | -24.07% |
| Jun 30, 2015 | -21.25% |
| Mar 31, 2015 | -18.91% |
| Dec 31, 2014 | -16.95% |
| Sep 30, 2014 | -15.32% |
| Jun 30, 2014 | -23.44% |
| Dec 31, 2013 | -21.50% |